Hua Medicine

Hua Medicine

Hua Medicine

Hua Medicine is a leading clinical-stage, innovative drug development company in China.
Founded
2010
Raised
$50M
Follow us
Alexa global traffic share
Latest funding
$50,000,000
Venture capital (Series C) - 2016
Harvest Global Investments
Team Size
10+
Employees
Location
Headquarters
AVCJ

Hua Medicine files for HK IPO under biotech fastrack

Funding
PE HUB

China's Hua Medicine plans $400 million Hong Kong IPO, led by Goldman, say sources: Reuters

Asia Health
$50,000,000 Venture capital (Series C)
BioPortfolio

Hua Medicine Lands $50 Million in a Series C Funding

Health